US Patent 8900252 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
Patent 8900252 was granted and assigned to Neotract on December, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8900252 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.